
MI-2
CAS No. 1047953-91-2
MI-2 ( MI 2 | MI2 )
产品货号. M10236 CAS No. 1047953-91-2
MI-2(MALT1 抑制剂)是一种选择性、不可逆的 MALT1 副半胱天冬酶抑制剂,IC50 为 5.84 uM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥437 | 有现货 |
![]() ![]() |
5MG | ¥794 | 有现货 |
![]() ![]() |
10MG | ¥1061 | 有现货 |
![]() ![]() |
25MG | ¥2049 | 有现货 |
![]() ![]() |
50MG | ¥3572 | 有现货 |
![]() ![]() |
100MG | ¥5257 | 有现货 |
![]() ![]() |
500MG | ¥11259 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称MI-2
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述MI-2(MALT1 抑制剂)是一种选择性、不可逆的 MALT1 副半胱天冬酶抑制剂,IC50 为 5.84 uM。
-
产品描述MI-2 (MALT1 inhibitor) is a selective, irreversible MALT1 paracaspase inhibitor with IC50 of 5.84 uM, displays little activity against the related caspase family members caspase-3, -8, and -9; inhibits cleavage of MALT1 substrates, which is accompanied by NF-κB reporter activity suppression, c-REL nuclear localization inhibition, and NF-κB target gene downregulation; specifically suppress ABC-DLBCL in vitro and in vivo, exhibits GI 50 of 0.2, 0.5, 0.4, and 0.4 uM for HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells respectively, inhibits nuclear translocation of RelB and p50, and decreases Bcl-xL levels in CLL cells.
-
体外实验MALT1 inhibitor MI-2 (1-1000 nM; 48 hours) selectively suppresses MALT1-dependent DLBCL cell lines, and the GI50 in HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells is 0.2, 0.5, 0.4, and 0.4 μM, respectively.MALT1 inhibitor MI-2 (62-1000 nM; 24 hours) causes a dose-dependent decrease in MALT1-mediated cleavage. Cell Proliferation Assay Cell Line:HBL-1, TMD8, OCI-Ly3, OCI-Ly10 cells Concentration:1, 10, 100, 1000 nM Incubation Time:48 hours Result:The GI50 in HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells was 0.2, 0.5, 0.4, and 0.4 μM, respectively.Western Blot Analysis Cell Line:HBL-1 cells Concentration:62, 125, 250, 500, 1000 nM Incubation Time:24 hours Result:Inhibits MALT1 cleavage of CYLD in HBL-1 cells.
-
体内实验MALT1 inhibitor MI-2 (25 mg/kg; i.p.; daily for 14 days) profoundly suppresses the growth of both the TMD8 and HBL-1 ABC-DLBCL xenografts. Animal Model:Eight-week-old male SCID NOD (bearing HBL-1 and TMD8 cells) Dosage:25 mg/kg Administration:Intraperitoneal injection; daily for 14 days Result:Profoundly suppressed the growth of both the TMD8 and HBL-1 ABC-DLBCL xenografts versus vehicle.
-
同义词MI 2 | MI2
-
通路NF-κB
-
靶点MALT1
-
受体MALT1
-
研究领域Inflammation/Immunology
-
适应症——
化学信息
-
CAS Number1047953-91-2
-
分子量455.7223
-
分子式C19H17Cl3N4O3
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 46 mg/mL
-
SMILESO=C(NC1=CC=C(N2N=C(OCCOC)N=C2C3=CC=C(Cl)C(Cl)=C3)C=C1)CCl
-
化学全称Acetamide, 2-chloro-N-[4-[5-(3,4-dichlorophenyl)-3-(2-methoxyethoxy)-1H-1,2,4-triazol-1-yl]phenyl]-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Fontan L, et al. Cancer Cell. 2012 Dec 11;22(6):812-24.
2. Saba NS, et al. Cancer Res. 2017 Dec 15;77(24):7038-7048.
3. Liu W, et al. Oncotarget. 2016 May 24;7(21):30536-49.
4. Yeh CN, et al. Oncotarget. 2017 Dec 8;8(69):113444-113459.
产品手册




关联产品
-
Mepazine hydrochlori...
Mepazine hydrochloride (Pecazine hydrochloride) 是一种有效的选择性 MALT1 蛋白酶抑制剂。Mepazine hydrochloride 抑制全长 GSTMALT1 和 GSTMALT1 325-760 段的IC50 分别为 0.83 和 0.42 μM。Mepazine hydrochloride 通过增强细胞凋亡 (apoptosis) 来影响 ABC-DLBCL 细胞的生存能力。
-
JNJ-67856633
JNJ-67856633 是一种口服活性、一流的、有效的、选择性的变构 MALT1 蛋白酶抑制剂。 JNJ-67856633在某些情况下会导致肿瘤瘀滞。
-
MLT943
MLT-943 是一种有效的、选择性的、具有口服活性的 MALT1 蛋白酶抑制剂。